Despite broad initiatives seeking improvements, the time it takes an individual with Duchenne muscular dystrophy (DMD) to get a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Treatment with the breast cancer medicine tamoxifen improved the functionality and survival of heart muscle cells in a cellular model…
The Spectrum Health Helen DeVos Children’s Hospital (HDVCH) in Michigan has been recognized as providing the highest quality of care…
An international team of scientists has developed a novel exon-skipping therapy mixture that has the potential to treat more than…
The U.S. Food and Drug Administration (FDA) has given Pfizer the go-ahead to open U.S. sites for the Phase…
A new natural history study that seeks to collect information about how Becker muscular dystrophy (BMD) progresses in the…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
When it comes to making decisions about how care goals should change for adolescent and young adults with Duchenne…
Four boys with Duchenne muscular dystrophy (DMD) show improved motor function and walking ability three years after being given the…
Boys with Duchenne muscular dystrophy (DMD) treated with the experimental gene therapy SGT-001 in the IGNITE DMD clinical…